World

Hydroxychloroquine Shows No Covid-19 Benefit in U.K. Study

Drug touted by Donald Trump has been center of controversy
Oxford study finds no reduction in virus patients’ death rates

Provide news feedback or report an error

Confidential tip?

Send a tip to our reporters

Site feedback:

Take our Survey

By James Paton and John Lauerman

June 5, 2020 at 3:00 PM UTC

Updated on

June 5, 2020 at 4:49 PM UTC

This article is for subscribers only.

Sign up here for our daily coronavirus newsletter on what you need to know, and subscribe to our Covid-19 podcast for the latest news and analysis.

A U.K. study of hydroxychloroquine for treatment of Covid-19 was halted after an early analysis found no benefit, the biggest blow yet for the therapy touted by U.S. President Donald Trump.